BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol 2019;80:303-17. [PMID: 29782900 DOI: 10.1016/j.jaad.2018.03.060] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 21.8] [Reference Citation Analysis]
Number Citing Articles
1 Durante G, Broseghini E, Comito F, Naddeo M, Milani M, Salamon I, Campione E, Dika E, Ferracin M. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer. Expert Rev Mol Diagn 2022. [PMID: 35235479 DOI: 10.1080/14737159.2022.2049243] [Reference Citation Analysis]
2 Ramírez-de Los Santos ML, López-Navarro A, Ramírez-de Los Santos S, Guzmán-Flores JM, Pereira-Suárez AL, López-Pulido EI. Relation between personality dimensions and symptomatology of depression in skin cancer patients. Biopsychosoc Med 2021;15:18. [PMID: 34641938 DOI: 10.1186/s13030-021-00220-3] [Reference Citation Analysis]
3 Goodall R, Chicco M, Wietek N, Borsky K, Harrison C, Rodrigues J. A systematic review of observational management of cutaneous basal cell carcinoma. J Plast Reconstr Aesthet Surg 2022:S1748-6815(22)00253-4. [PMID: 35680535 DOI: 10.1016/j.bjps.2022.04.056] [Reference Citation Analysis]
4 Roy V, Magne B, Vaillancourt-Audet M, Blais M, Chabaud S, Grammond E, Piquet L, Fradette J, Laverdière I, Moulin VJ, Landreville S, Germain L, Auger FA, Gros-Louis F, Bolduc S. Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors. Biomed Res Int 2020;2020:6051210. [PMID: 32352002 DOI: 10.1155/2020/6051210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
5 de Wet J, Steyn M, Jordaan HF, Smith R, Claasens S, Visser WI. An Analysis of Biopsies for Suspected Skin Cancer at a Tertiary Care Dermatology Clinic in the Western Cape Province of South Africa. J Skin Cancer 2020;2020:9061532. [PMID: 32411476 DOI: 10.1155/2020/9061532] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Gompertz-Mattar M, Perales J, Sahu A, Mondaca S, Gonzalez S, Uribe P, Navarrete-Dechent C. Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes. Arch Dermatol Res 2021. [PMID: 34647186 DOI: 10.1007/s00403-021-02289-w] [Reference Citation Analysis]
7 Peters N, Schubert M, Geppert JP, Moehrle M. Micrographic controlled surgery of basal cell carcinomas: rapid lump examination in comparison with haematoxylin and eosin-stained paraffin sections. Br J Dermatol 2019;181:399-400. [PMID: 30729494 DOI: 10.1111/bjd.17740] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Weissman JP, Samlowski W, Meoz R. Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series. Oncologist 2021. [PMID: 34472658 DOI: 10.1002/onco.13959] [Reference Citation Analysis]
9 Barrios DM, Do MH, Phillips GS, Postow MA, Akaike T, Nghiem P, Lacouture ME. Immune checkpoint inhibitors to treat cutaneous malignancies. J Am Acad Dermatol 2020;83:1239-53. [PMID: 32461079 DOI: 10.1016/j.jaad.2020.03.131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
10 Mi X, Lai K, Yan L, Xie S, Qiu X, Xiao S, Wei S. miR-18a expression in basal cell carcinoma and regulatory mechanism on autophagy through mTOR pathway. Clin Exp Dermatol 2020;45:1027-34. [PMID: 32485050 DOI: 10.1111/ced.14322] [Reference Citation Analysis]
11 Souto EB, da Ana R, Vieira V, Fangueiro JF, Dias-ferreira J, Cano A, Zielińska A, Silva AM, Staszewski R, Karczewski J. Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments. Neoplasia 2022;30:100810. [DOI: 10.1016/j.neo.2022.100810] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kim DP, Kus KJB, Ruiz E. Basal Cell Carcinoma Review. Hematol Oncol Clin North Am 2019;33:13-24. [PMID: 30497670 DOI: 10.1016/j.hoc.2018.09.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
13 Hendel K, Jemec GBE, Haedersdal M, Wiegell SR. Electrochemotherapy with bleomycin for basal cell carcinomas: a systematic review. J Eur Acad Dermatol Venereol 2021. [PMID: 34219303 DOI: 10.1111/jdv.17492] [Reference Citation Analysis]
14 Soutou B, Massih C, Sleilaty G, Trak-smayra V, Nasr M, Helou J, Hokayem N, Ferran F, Sleilati FH, Stéphan F, Halabi-tawil M, Tomb R. Clinical and pathological features associated with high-risk, multiple, and recurrent basal cell carcinomas: a retrospective cohort analysis from the Levantine coast of the Mediterranean Sea. Arch Dermatol Res. [DOI: 10.1007/s00403-021-02316-w] [Reference Citation Analysis]
15 Carrasquillo OY, Cruzval-O'Reilly E, Sánchez JE, Valentín-Nogueras SM. Differentiation of Basal Cell Carcinoma and Trichoepithelioma: An Immunohistochemical Study. Am J Dermatopathol 2021;43:191-7. [PMID: 32809979 DOI: 10.1097/DAD.0000000000001783] [Reference Citation Analysis]
16 Amini A, Freeman M, Melstrom L, Margolin KA, Parekh V, Abdulla FR, Modi B. Pathologic complete response with radiation and vismodegib in a patient with advanced basal cell carcinoma: A case report. Mol Clin Oncol 2021;14:46. [PMID: 33575030 DOI: 10.3892/mco.2021.2208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dika E, Veronesi G, Patrizi A, De Salvo S, Misciali C, Baraldi C, Mussi M, Fabbri E, Tartari F, Lambertini M. It's time for Mohs: Micrographic surgery for the treatment of high-risk basal cell carcinomas of the head and neck regions. Dermatol Ther 2020;33:e13474. [PMID: 32391961 DOI: 10.1111/dth.13474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Ozkanli S, Soylemez T, Keskin H, Seneldir H, Sahin FM, Çetinkaya A, Gokturk A, Aycicek N, Duz K, Cobanoglu Simsek B. A Five-Year Retrospective Analysis of Basal Cell Carcinoma: A Monocentric Study. Medeni Med J 2020;35:219-25. [PMID: 33110674 DOI: 10.5222/MMJ.2020.92332] [Reference Citation Analysis]
19 Bernhard GH, Neale RE, Barnes PW, Neale PJ, Zepp RG, Wilson SR, Andrady AL, Bais AF, McKenzie RL, Aucamp PJ, Young PJ, Liley JB, Lucas RM, Yazar S, Rhodes LE, Byrne SN, Hollestein LM, Olsen CM, Young AR, Robson TM, Bornman JF, Jansen MAK, Robinson SA, Ballaré CL, Williamson CE, Rose KC, Banaszak AT, Häder D-, Hylander S, Wängberg S-, Austin AT, Hou W-, Paul ND, Madronich S, Sulzberger B, Solomon KR, Li H, Schikowski T, Longstreth J, Pandey KK, Heikkilä AM, White CC. Environmental effects of stratospheric ozone depletion, UV radiation and interactions with climate change: UNEP Environmental Effects Assessment Panel, update 2019. Photochem Photobiol Sci 2020;19:542-84. [PMID: 32364555 DOI: 10.1039/d0pp90011g] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 16.0] [Reference Citation Analysis]
20 Collier NJ, Rhodes LE. Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities. Molecules 2020;25:E5398. [PMID: 33218174 DOI: 10.3390/molecules25225398] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
21 Khan NH, Mir M, Qian L, Baloch M, Ali Khan MF, Rehman A, Ngowi EE, Wu D, Ji X. Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures. Journal of Advanced Research 2022;36:223-47. [DOI: 10.1016/j.jare.2021.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Jones OT, Ranmuthu CKI, Hall PN, Funston G, Walter FM. Recognising Skin Cancer in Primary Care. Adv Ther 2020;37:603-16. [PMID: 31734824 DOI: 10.1007/s12325-019-01130-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
23 Vaidya TS, Mori S, Khoshab N, Dusza SW, Bander T, Matros E, Rossi AM, Nehal KS, Lee EH. Patient-reported Aesthetic Satisfaction following Facial Skin Cancer Surgery Using the FACE-Q Skin Cancer Module. Plast Reconstr Surg Glob Open 2019;7:e2423. [PMID: 31942391 DOI: 10.1097/GOX.0000000000002423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
24 Kash N, Silapunt S. A review of emerging and non-US FDA-approved topical agents for the treatment of basal cell carcinoma. Future Oncol 2021;17:3111-32. [PMID: 34156307 DOI: 10.2217/fon-2020-1147] [Reference Citation Analysis]
25 Vaidya TS, Mori S, Dusza SW, Rossi AM, Nehal KS, Lee EH. Appearance-related psychosocial distress following facial skin cancer surgery using the FACE-Q Skin Cancer. Arch Dermatol Res 2019;311:691-6. [PMID: 31338583 DOI: 10.1007/s00403-019-01957-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 Pagnoni A, Giroud S, Koulouri A, Hohl D, Gaide O. White Globules in Basal Cell Carcinoma: A Dermoscopic Sign With Preoperative Implications. Dermatol Pract Concept 2021;11:e2021103. [PMID: 33614202 DOI: 10.5826/dpc.1101a103] [Reference Citation Analysis]
27 Council ML. Commentary on "In vivo imaging characterization of basal cell carcinoma cutaneous response to high-dose ionizing radiation therapy: A prospective study of reflectance confocal microscopy, dermoscopy, and ultrasound". J Am Acad Dermatol 2021;84:1792-3. [PMID: 32827606 DOI: 10.1016/j.jaad.2020.08.066] [Reference Citation Analysis]
28 Gabriel JA, Shams M, Orchard GE. Evaluation of different haematoxylin stain subtypes for the optimal microscopic interpretation of cutaneous malignancy in Mohs frozen section histological procedure. Br J Biomed Sci 2021;78:78-86. [PMID: 33054567 DOI: 10.1080/09674845.2020.1838075] [Reference Citation Analysis]
29 Fania L, Samela T, Moretta G, Ricci F, Dellambra E, Mancini M, Sampogna F, Panebianco A, Abeni D. Attitudes among dermatologists regarding non-melanoma skin cancer treatment options. Discov Onc 2021;12. [DOI: 10.1007/s12672-021-00421-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bisceglia M, Panniello G, Galliani CA, Centola M, D'Errico MM, Minenna E, Tucci FA, Ben-Dor DJ. Metastatic Basal Cell Carcinoma of the Skin: A Comprehensive Literature Review, Including Advances in Molecular Therapeutics. Adv Anat Pathol 2020;27:331-53. [PMID: 32618586 DOI: 10.1097/PAP.0000000000000267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
31 Baek YS, Kim A, Seo JY, Jeon J, Oh CH, Kim J. Dynamic thermal imaging for pigmented basal cell carcinoma and seborrheic keratosis. Int J Hyperthermia 2021;38:1462-8. [PMID: 34620028 DOI: 10.1080/02656736.2021.1986142] [Reference Citation Analysis]
32 Fagotti S, Pizzichetta MA, Corneli P, Toffolutti F, Serraino D, di Meo N, Zalaudek I. Dermoscopic features of face and scalp basal and squamous cell carcinomas according to clinical histopathologic characteristics and anatomical location. J Eur Acad Dermatol Venereol 2021;35:e237-9. [PMID: 32986897 DOI: 10.1111/jdv.16968] [Reference Citation Analysis]
33 Gambini D, Passoni E, Nazzaro G, Beltramini G, Tomasello G, Ghidini M, Kuhn E, Garrone O. Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response. Front Med 2022;9:893063. [DOI: 10.3389/fmed.2022.893063] [Reference Citation Analysis]
34 Akhtar S, Rajabi-Estarabadi A, Kamath P, Dong J, Nouri K. Cells to Surgery Quiz: April 2021. J Invest Dermatol 2021;141:e43-9. [PMID: 33752814 DOI: 10.1016/j.jid.2021.02.006] [Reference Citation Analysis]
35 Duarte B, Vieira L, Pessoa E Costa T, Ribeiro L, João A, Cabete J, Varanda A. Predicting incomplete basal cell carcinoma excisions - a large multidisciplinary retrospective analysis in a tertiary center. J Dermatolog Treat 2020;31:583-8. [PMID: 31689139 DOI: 10.1080/09546634.2019.1687815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Fosko SW, Chu MB, Armbrecht E, Galperin T, Potts GA, Mattox A, Kurta A, Polito K, Slutsky JB, Burkemper NM, Hurley MY. Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial. J Am Acad Dermatol 2020;82:946-54. [PMID: 31836564 DOI: 10.1016/j.jaad.2019.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Wenande E, Hendel K, Mogensen M, Bagger C, Mårtensson NL, Persson DP, Lerche CM, Husted S, Janfelt C, Togsverd-Bo K, Anderson RR, Haedersdal M. Efficacy and Safety of Laser-Assisted Combination Chemotherapy: An Explorative Imaging-Guided Treatment With 5-Fluorouracil and Cisplatin for Basal Cell Carcinoma. Lasers Surg Med 2021;53:119-28. [PMID: 32960987 DOI: 10.1002/lsm.23323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Kasumagic-Halilovic E, Hasic M, Ovcina-Kurtovic N. A Clinical Study of Basal Cell Carcinoma. Med Arch 2019;73:394-8. [PMID: 32082007 DOI: 10.5455/medarh.2019.73.394-398] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
39 Castanheira A, Boaventura P, Pais Clemente M, Soares P, Mota A, Lopes JM. Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about? Acta Otorhinolaryngol Ital 2020;40:5-18. [PMID: 31388193 DOI: 10.14639/0392-100X-2245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
40 Zhang W, Zeng W, Jiang A, He Z, Shen X, Dong X, Feng J, Lu H. Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019. Cancer Med 2021;10:4905-22. [PMID: 34105887 DOI: 10.1002/cam4.4046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Łasińska I, Zielińska A, Mackiewicz J, Souto EB. Basal Cell Carcinoma: Pathology, Current Clinical Treatment, and Potential Use of Lipid Nanoparticles. Cancers 2022;14:2778. [DOI: 10.3390/cancers14112778] [Reference Citation Analysis]
42 Maqueda Ara S, Del Barrio Fernández M, Suárez González LÁ. Malignant wounds: Basal cell carcinoma presenting as a nonhealing ulceration on an arteriovenous fistula. J Vasc Access 2021;22:682-4. [PMID: 32648831 DOI: 10.1177/1129729820940183] [Reference Citation Analysis]
43 Amr Gamal F, Kharshoum RM, Sayed OM, El-ela FIA, Salem HF. Control of basal cell carcinoma via positively charged ethosomes of Vismodegib: In vitro and in vivo studies. Journal of Drug Delivery Science and Technology 2020;56:101556. [DOI: 10.1016/j.jddst.2020.101556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
44 Gao X, Zhang Y, Han X, Li Z, Chen B, Li Q, Hu L, Lv Y, Ren F. Numerical analysis and animal study of noninvasive handheld electroporation delivery device for skin superficial lesion treatment. Int J Hyperthermia 2022;39:1017-25. [PMID: 35912525 DOI: 10.1080/02656736.2022.2104937] [Reference Citation Analysis]
45 Kentley J, Allawh R, Rao S, Doyle A, Ahmad A, Nadhan K, Proby C, Harwood CA, Chung CL. The burden of cutaneous disease in solid organ transplant recipients of color. Am J Transplant 2021;21:1215-26. [PMID: 32659869 DOI: 10.1111/ajt.16210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
46 Durante G, Comito F, Lambertini M, Broseghini E, Dika E, Ferracin M. Non-coding RNA dysregulation in skin cancers. Essays Biochem 2021;65:641-55. [PMID: 34414406 DOI: 10.1042/EBC20200048] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Monnet P, Herms F, Djermane M, Dalac S, Dereure O, Dréno B, Beylot-Barry M, Mortier L, Basset-Seguin N. Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors. Br J Dermatol 2021. [PMID: 34817864 DOI: 10.1111/bjd.20808] [Reference Citation Analysis]
48 Markowitz O, Bressler MY. Combining Nd:YAG laser with optical coherence tomography for nonsurgical treatment of basal cell carcinoma. Lasers Surg Med 2021. [PMID: 34289512 DOI: 10.1002/lsm.23455] [Reference Citation Analysis]
49 Morgan FC, Ruiz ES, Karia PS, Besaw RJ, Neel VA, Schmults CD. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death. J Am Acad Dermatol 2021;85:582-7. [PMID: 33497751 DOI: 10.1016/j.jaad.2021.01.052] [Reference Citation Analysis]
50 Gellatly M, Cruzval-O'Reilly E, Mervak JE, Mervak BM. Metastatic basal cell carcinoma with atypical pattern of spread. Radiol Case Rep 2020;15:2641-4. [PMID: 33088379 DOI: 10.1016/j.radcr.2020.09.054] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Cojocaru A, Marinescu EA, Nica O, Ilinoiu E, Negrila A, Ciurea ME. Basal Cell Carcinoma and its Impact on Different Anatomical Regions. Curr Health Sci J 2021;47:75-83. [PMID: 34211751 DOI: 10.12865/CHSJ.47.01.12] [Reference Citation Analysis]
52 Niculet E, Craescu M, Rebegea L, Bobeica C, Nastase F, Lupasteanu G, Stan DJ, Chioncel V, Anghel L, Lungu M, Tatu AL. Basal cell carcinoma: Comprehensive clinical and histopathological aspects, novel imaging tools and therapeutic approaches (Review). Exp Ther Med 2022;23:60. [PMID: 34917186 DOI: 10.3892/etm.2021.10982] [Reference Citation Analysis]
53 Peters N, Schubert M, Bauer J, Ghoreschi FC, Moehrle M. Rapid Lump Examination (RLE) - eine schnelle Methode in der mikroskopisch kontrollierten Chirurgie von Basalzellkarzinomen. J Dtsch Dermatol Ges 2019;17:1131-40. [PMID: 31765084 DOI: 10.1111/ddg.13937_g] [Reference Citation Analysis]
54 Di Nardo L, Pellegrini C, Di Stefani A, Ricci F, Fossati B, Del Regno L, Carbone C, Piro G, Corbo V, Delfino P, De Summa S, Maturo MG, Rocco T, Tortora G, Fargnoli MC, Peris K. Molecular alterations in basal cell carcinoma subtypes. Sci Rep 2021;11:13206. [PMID: 34168209 DOI: 10.1038/s41598-021-92592-3] [Reference Citation Analysis]
55 Azzopardi EA, Abdelrahman W, Azzopardi E, O'Leary B, Yarrow J, Miles N, Barbara C, Camilleri L, Clementoni MT, Murison M. Treatment of cutaneous basal cell carcinoma with combined laser extirpation and methyl aminolevulinic acid: five-year success rates. Ann R Coll Surg Engl 2021;103:263-71. [PMID: 33557701 DOI: 10.1308/rcsann.2020.7020] [Reference Citation Analysis]
56 Moscarella E, Brancaccio G, Briatico G, Ronchi A, Verolino P, Argenziano G, Alfano R. Management of advanced basal cell carcinoma: Real-life data with sonidegib. Dermatol Ther 2021;34:e14948. [PMID: 33728757 DOI: 10.1111/dth.14948] [Reference Citation Analysis]
57 Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, Cavallo F, Giudice G, Stucci LS, Porta C, Tucci M. Non-Melanoma Skin Cancers: Biological and Clinical Features. Int J Mol Sci 2020;21:E5394. [PMID: 32751327 DOI: 10.3390/ijms21155394] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
58 Caruana M, Morand M, Belisle A, Nantel-Battista M. Basal cell carcinoma stroma as a mimicker of lymphatic invasion: A case report. SAGE Open Med Case Rep 2020;8:2050313X20919602. [PMID: 32477557 DOI: 10.1177/2050313X20919602] [Reference Citation Analysis]
59 Abadin AA, Fosko S, Boniface M, Presutti RJ. Delayed Presentation of Basal Cell Carcinoma: A Case Report. Cureus 2020;12:e10695. [PMID: 33133860 DOI: 10.7759/cureus.10695] [Reference Citation Analysis]
60 Tronconi MC, Solferino A, Giordano L, Borroni R, Mancini L, Santoro A. Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis. Front Oncol 2020;10:563404. [PMID: 33282729 DOI: 10.3389/fonc.2020.563404] [Reference Citation Analysis]
61 Conforti C, Pizzichetta MA, Vichi S, Toffolutti F, Serraino D, Di Meo N, Giuffrida R, Deinlein T, Giacomel J, Rosendahl C, Gourhant JY, Zalaudek I. Sclerodermiform basal cell carcinomas vs. other histotypes: analysis of specific demographic, clinical and dermatoscopic features. J Eur Acad Dermatol Venereol 2021;35:79-87. [PMID: 32401364 DOI: 10.1111/jdv.16597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Xavier-Júnior JCC, Ocanha-Xavier JP, Camilo-Júnior DJ, Pires D'ávilla SCG, Mattar NJ. Is pigmented BCC a unique histological variant or is it only a clinical presentation? Australas J Dermatol 2020;61:80-1. [PMID: 31625594 DOI: 10.1111/ajd.13181] [Reference Citation Analysis]
63 Marous M, Mueller K, Tausk F. Multiple basal cell carcinomas in Gorlin Syndrome treated with pulsed dye laser. J Cosmet Laser Ther 2020;22:230-1. [PMID: 33849368 DOI: 10.1080/14764172.2021.1914852] [Reference Citation Analysis]
64 Villani A, Fabbrocini G, Costa C, Scalvenzi M. Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma. Dermatol Ther (Heidelb) 2020;10:401-12. [PMID: 32297221 DOI: 10.1007/s13555-020-00378-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
65 El-khalawany M, Hassab-el-naby HMM, Mousa AM, Sameh A, Rageh MA, Genedy RM, Hosny AM, Aboelmagd MA, Aboeldahab S. Epidemiological and clinicopathological analysis of basal cell carcinoma in Egyptian population: a 5-year retrospective multicenter study. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-022-04207-7] [Reference Citation Analysis]
66 Erickson SP, Foshee JP, Council ML. Cells to Surgery Quiz: May 2021. J Invest Dermatol 2021;141:e59-63. [PMID: 33888220 DOI: 10.1016/j.jid.2021.03.003] [Reference Citation Analysis]
67 Aggarwal P, Knabel P, Fleischer AB Jr. United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. J Am Acad Dermatol 2021;85:388-95. [PMID: 33852922 DOI: 10.1016/j.jaad.2021.03.109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Gubarkova EV, Feldchtein FI, Zagaynova EV, Gamayunov SV, Sirotkina MA, Sedova ES, Kuznetsov SS, Moiseev AA, Matveev LA, Zaitsev VY, Karashtin DA, Gelikonov GV, Pires L, Vitkin A, Gladkova ND. Optical coherence angiography for pre-treatment assessment and treatment monitoring following photodynamic therapy: a basal cell carcinoma patient study. Sci Rep 2019;9:18670. [PMID: 31822752 DOI: 10.1038/s41598-019-55215-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
69 Nguyen TT, Tarapore E, Atwood SX. Common Skin Diseases. In: Xu C, Wang X, Pramanik M, editors. Imaging Technologies and Transdermal Delivery in Skin Disorders. Wiley; 2019. pp. 83-103. [DOI: 10.1002/9783527814633.ch5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Bednarski IA, Ciążyńska M, Wódz K, Dróżdż I, Skibińska M, Narbutt J, Lesiak A. Hippo Signaling Pathway as a New Potential Target in Non-Melanoma Skin Cancers: A Narrative Review. Life (Basel) 2021;11:680. [PMID: 34357052 DOI: 10.3390/life11070680] [Reference Citation Analysis]
71 Villani A, Fabbrocini G, Costa C, Scalvenzi M. Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma. Dermatol Ther (Heidelb) 2020;10:401-12. [PMID: 32297221 DOI: 10.1007/s13555-020-00378-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 10.5] [Reference Citation Analysis]
72 Rahman J, Tahir M, Arekemase H, Murtazaliev S, Sonawane S. Desmoplastic Trichoepithelioma: Histopathologic and Immunohistochemical Criteria for Differentiation of a Rare Benign Hair Follicle Tumor From Other Cutaneous Adnexal Tumors. Cureus 2020;12:e9703. [PMID: 32923292 DOI: 10.7759/cureus.9703] [Reference Citation Analysis]
73 Peters N, Schubert M, Bauer J, Ghoreschi FC, Moehrle M. Rapid Lump Examination (RLE) – a bedside 3‐dimensional microscopy of tumor specimens. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2019;17:1131-9. [DOI: 10.1111/ddg.13937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Pandey M, Choudhury H, Gorain B, Tiong SQ, Wong GYS, Chan KX, They X, Chieu WS. Site-Specific Vesicular Drug Delivery System for Skin Cancer: A Novel Approach for Targeting. Gels 2021;7:218. [PMID: 34842689 DOI: 10.3390/gels7040218] [Reference Citation Analysis]
75 Zhang C, Zhu X, Hou S, Pan W, Liao W. Functionalization of Nanomaterials for Skin Cancer Theranostics. Front Bioeng Biotechnol 2022;10:887548. [DOI: 10.3389/fbioe.2022.887548] [Reference Citation Analysis]
76 Livingston-Rosanoff D, Foley DP, Leverson G, Wilke LG. Impact of Pre-Transplant Malignancy on Outcomes After Kidney Transplantation: United Network for Organ Sharing Database Analysis. J Am Coll Surg 2019;229:568-79. [PMID: 31666186 DOI: 10.1016/j.jamcollsurg.2019.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
77 Villani A, Fabbrocini G, Costa C, Ocampo-Garza SS, Lallas A, Scalvenzi M. Expert opinion on sonidegib efficacy, safety and tolerability. Expert Opin Drug Saf 2021;20:877-82. [PMID: 33888008 DOI: 10.1080/14740338.2021.1921734] [Reference Citation Analysis]
78 Moujaess E, Merhy R, Kattan J, Sarkis AS, Tomb R. Immune checkpoint inhibitors for advanced or metastatic basal cell carcinoma: how much evidence do we need? Immunotherapy 2021;13:1293-304. [PMID: 34463126 DOI: 10.2217/imt-2021-0089] [Reference Citation Analysis]
79 Wright CY, Norval M, Kapwata T, du Preez DJ, Wernecke B, Tod BM, Visser WI. The Incidence of Skin Cancer in Relation to Climate Change in South Africa. Atmosphere 2019;10:634. [DOI: 10.3390/atmos10100634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Gallo JC, Schneider JW, de Wet J, Moxley K, Jordaan HF, Visser WI, Tod B, Kimyai Asadi A. A Profile and Three-Year Follow-Up of Patients with Basal Cell Carcinoma in the Western Cape, South Africa. Journal of Skin Cancer 2022;2022:1-7. [DOI: 10.1155/2022/8443867] [Reference Citation Analysis]
81 Sendín-Martin M, Hernández-Rodríguez JC, Durán-Romero AJ, Ortiz-Álvarez J, Conejo-Mir J, Pereyra-Rodríguez JJ. Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044. J Clin Med 2021;10:5750. [PMID: 34945046 DOI: 10.3390/jcm10245750] [Reference Citation Analysis]
82 Kaur H, Kesharwani P. Advanced nanomedicine approaches applied for treatment of skin carcinoma. J Control Release 2021;337:589-611. [PMID: 34364919 DOI: 10.1016/j.jconrel.2021.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Sheng S, Qi S, Pan J, Qin X. Excision margin of T3 basal cell carcinoma in maxillofacial area: A retrospective cohort study of Asians. Oral Dis 2020. [PMID: 33274605 DOI: 10.1111/odi.13742] [Reference Citation Analysis]
84 Sabri AH, Cater Z, Gurnani P, Ogilvie J, Segal J, Scurr DJ, Marlow M. Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma. International Journal of Pharmaceutics 2020;589:119808. [DOI: 10.1016/j.ijpharm.2020.119808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
85 Banzhaf C, Phothong W, Suku M, Ulrich M, Philipsen P, Mogensen M, Haedersdal M. Basal cell carcinoma treated with combined ablative fractional laser and ingenol mebutate – an exploratory study monitored by optical coherence tomography and reflectance confocal microscopy. J Eur Acad Dermatol Venereol 2019;34:502-9. [DOI: 10.1111/jdv.15907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
86 Leone A, Martínez-González MÁ, Martin-Gorgojo A, Sánchez-Bayona R, De Amicis R, Bertoli S, Battezzati A, Bes-Rastrollo M. Mediterranean diet, Dietary Approaches to Stop Hypertension, and Pro-vegetarian dietary pattern in relation to the risk of basal cell carcinoma: a nested case-control study within the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr 2020;112:364-72. [PMID: 32492135 DOI: 10.1093/ajcn/nqaa127] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Cohen PR. Basal cell carcinoma: Additional subtypes and therapeutic advances. J Am Acad Dermatol 2019;81:e17. [PMID: 30802559 DOI: 10.1016/j.jaad.2019.02.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
88 Shallis RM, Bewersdorf JP, Boddu PC, Zeidan AM. Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia. Expert Rev Anticancer Ther 2019;19:717-29. [PMID: 31422721 DOI: 10.1080/14737140.2019.1652095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
89 Adalsteinsson JA, Ratner D, Olafsdóttir E, Grant-Kels J, Ungar J, Silverberg JI, Kristjansson AK, Jonasson JG, Tryggvadottir L. Basal cell carcinoma: an emerging epidemic in women in Iceland. Br J Dermatol 2020;183:847-56. [PMID: 32030719 DOI: 10.1111/bjd.18937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
90 Guerrero-Juarez CF, Lee GH, Liu Y, Wang S, Karikomi M, Sha Y, Chow RY, Nguyen TTL, Iglesias VS, Aasi S, Drummond ML, Nie Q, Sarin K, Atwood SX. Single-cell analysis of human basal cell carcinoma reveals novel regulators of tumor growth and the tumor microenvironment. Sci Adv 2022;8:eabm7981. [PMID: 35687691 DOI: 10.1126/sciadv.abm7981] [Reference Citation Analysis]
91 Kim M, Kim JW, Shin JW, Na JI, Huh CH. Basal cell carcinoma of the scalp shows distinct features from the face in Asians. Sci Rep 2022;12:10183. [PMID: 35715697 DOI: 10.1038/s41598-022-14533-y] [Reference Citation Analysis]
92 Doan HQ, Chen L, Nawas Z, Lee HH, Silapunt S, Migden M. Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma. Oncotarget 2021;12:2089-100. [PMID: 34611482 DOI: 10.18632/oncotarget.28080] [Reference Citation Analysis]
93 de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J 2022;28:263-9. [PMID: 35880935 DOI: 10.1097/PPO.0000000000000610] [Reference Citation Analysis]
94 Damsin T, Lebas E, Marchal N, Rorive A, Nikkels AF. Cemiplimab for locally advanced and metastatic basal cell carcinoma. Expert Rev Anticancer Ther 2022. [PMID: 35175882 DOI: 10.1080/14737140.2022.2043748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Onodera S, Nakamura Y, Azuma T. Gorlin Syndrome: Recent Advances in Genetic Testing and Molecular and Cellular Biological Research. Int J Mol Sci 2020;21:E7559. [PMID: 33066274 DOI: 10.3390/ijms21207559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
96 van Egmond S, van Vliet ED, Wakkee M, Hollestein LM, Pouwels XGLV, Koffijberg H, Misirli Y, Bakkum RSLA, Bastiaens MT, Kukutsch NA, Oosting AJ, Plasmeijer EI, van Rengen A, de Roos KP, Nijsten TEC, de Vries E, de Bekker-Grob EW. Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care. PLoS One 2022;17:e0260978. [PMID: 35073333 DOI: 10.1371/journal.pone.0260978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Fathi F, Zamani B, Piroozmand A, Mozafarpoor S, Seyedhashemi E, ArefNezhad R, Motedayyen H. Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma. Mol Biol Rep 2021;48:2047-52. [PMID: 33389528 DOI: 10.1007/s11033-020-06115-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Lee KJ, Soyer HP. Cutaneous keratinocyte cancers of the head and neck: Epidemiology, risk factors and clinical, dermoscopic and reflectance confocal microscopic features. Oral Oncol 2019;98:109-17. [PMID: 31585338 DOI: 10.1016/j.oraloncology.2019.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
99 Pineider J, Ken KM, Savory S, Nijhawan RI. Basal cell carcinoma masquerading as vitiligo in a young woman. JAAD Case Rep 2020;6:584-6. [PMID: 32685644 DOI: 10.1016/j.jdcr.2020.05.006] [Reference Citation Analysis]
100 Lee KJ, Soyer HP. Smartphones, artificial intelligence and digital histopathology take on basal cell carcinoma diagnosis. Br J Dermatol 2020;182:540-1. [PMID: 31429070 DOI: 10.1111/bjd.18374] [Reference Citation Analysis]
101 TaslÎca R, Georgescu CV, PĂtraŞcu V. Adenoid Cystic Basal Cell Carcinoma Arising in Rhinophyma. Curr Health Sci J 2020;46:309-14. [PMID: 33304635 DOI: 10.12865/CHSJ.46.03.15] [Reference Citation Analysis]
102 Tripathi R, Ezaldein HH, Rajkumar K, Bordeaux JS, Scott JF. Characteristics of State and Federal Malpractice Litigation of Medical Liability Claims for Keratinocyte Carcinoma, 1968 to 2018. JAMA Dermatol 2019;155:812-8. [PMID: 31090874 DOI: 10.1001/jamadermatol.2019.0430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
103 Li Y, Li Y, Li L. Circular RNA hsa_Circ_0005795 mediates cell proliferation of cutaneous basal cell carcinoma via sponging miR-1231. Arch Dermatol Res 2021. [PMID: 33433717 DOI: 10.1007/s00403-020-02174-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Claasens S, Kannenberg SMH, Jordaan HF, Moxley K, Smith R, de Wet J, Visser WI. The prevalence and spectrum of mucocutaneous disease in South African people living with HIV and accessing care at a district-level hospital. South Afr J HIV Med 2020;21:1154. [PMID: 33354365 DOI: 10.4102/sajhivmed.v21i1.1154] [Reference Citation Analysis]
105 Borgheti-Cardoso LN, Viegas JSR, Silvestrini AVP, Caron AL, Praça FG, Kravicz M, Bentley MVLB. Nanotechnology approaches in the current therapy of skin cancer. Adv Drug Deliv Rev 2020;153:109-36. [PMID: 32113956 DOI: 10.1016/j.addr.2020.02.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 15.5] [Reference Citation Analysis]
106 O'Connell KA, Conran RM. Educational Case: Basal Cell Carcinoma. Acad Pathol 2021;8:2374289521998030. [PMID: 33763533 DOI: 10.1177/2374289521998030] [Reference Citation Analysis]
107 Villani A, Potestio L, Fabbrocini G, Scalvenzi M. New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma. Adv Ther 2022;39:1164-78. [PMID: 35089534 DOI: 10.1007/s12325-022-02044-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Adalsteinsson JA, Olafsdottir E, Ratner D, Waldman R, Feng H, Ungar J, Silverberg JI, Kristjansson AK, Jonasson JG, Tryggvadottir L. Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland. Br J Dermatol 2021;185:537-47. [PMID: 33609287 DOI: 10.1111/bjd.19879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Najmi M, Sivesind TE, Thomson J, Hogan S, Dellavalle RP. From the Cochrane Library: Interventions for basal cell carcinoma of the skin. J Am Acad Dermatol 2021:S0190-9622(21)02391-4. [PMID: 34499991 DOI: 10.1016/j.jaad.2021.08.046] [Reference Citation Analysis]